Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
Dima A. Sabbah, Rima Hajjo, Kamal Sweidan
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 10, pp. 815-834
Closed Access | Times Cited: 408

Showing 1-25 of 408 citing articles:

Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 117
Emerging strategies to overcome resistance to third-generation EGFR inhibitors
Kunyu Shi, Guan Wang, Junping Pei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 107
Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Beiyuan Hu, Tiantian Zou, Wei Qin, et al.
Cancer Research (2022) Vol. 82, Iss. 20, pp. 3845-3857
Open Access | Times Cited: 88
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Targeted therapy for osteosarcoma: a review
Shizhe Li, He Zhang, Jinxin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6785-6797
Closed Access | Times Cited: 47
Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
Yufeng Li, Tianyu Mao, Jing Wang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 44
VEGF and EGFR signaling pathways are involved in the baicalein attenuation of OVA-induced airway inflammation and airway remodeling in mice
Peng Wang, Qinxuan Xia, Yue Zhang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 17
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition
María A. Ortiz, Tatiana Mikhailova, Xiang Li, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 103
The Critical Role of Growth Factors in Gastric Ulcer Healing: The Cellular and Molecular Mechanisms and Potential Clinical Implications
Andrzej S. Tarnawski, Amrita Ahluwalia
Cells (2021) Vol. 10, Iss. 8, pp. 1964-1964
Open Access | Times Cited: 96
Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19
Rong Li, Ka Wu, Yu Li, et al.
Aging (2020) Vol. 12, Iss. 15, pp. 15784-15796
Open Access | Times Cited: 88
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
Ahmed Elkamhawy, Qili Lu, Hossam Nada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6535-6535
Open Access | Times Cited: 74
Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
Cristina Aparicio, Marina Belver, Lucía Enríquez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11781-11781
Open Access | Times Cited: 62
Desmosomes as Signaling Hubs in the Regulation of Cell Behavior
Lisa Müller, Meçhthild Hatzfeld, René Keil
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 58
Can EGFR be a therapeutic target in breast cancer?
Xi‐Yin Li, Lina Zhao, Ceshi Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188789-188789
Closed Access | Times Cited: 45
Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance
Joanna Pastwińska, Kaja Karaś, Iwona Karwaciak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188754-188754
Open Access | Times Cited: 42
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Mian Huang, Bingtao Zhai, Yu Fan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4275-4311
Open Access | Times Cited: 40
Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies
Andrea Monti Hughes, Naonori Hu
Cancers (2023) Vol. 15, Iss. 16, pp. 4091-4091
Open Access | Times Cited: 39
EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
Hee-Jeong Choi, Yoo Joo Jeong, Ji‐Eun Kim, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review)
Zhinan Cheng, Hongwei Cui, Yaqi Wang, et al.
Oncology Reports (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 26
Is Candida albicans a contributor to cancer? A critical review based on the current evidence
Xu Wang, Wenqing Zhang, Wenjie Wu, et al.
Microbiological Research (2023) Vol. 272, pp. 127370-127370
Open Access | Times Cited: 24
Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction
Özkan İş, Xue Wang, Joseph S. Reddy, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Degraders in epigenetic therapy: PROTACs and beyond
Xing‐Jie Dai, Shi‐Kun Ji, Meng‐Jie Fu, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1464-1499
Open Access | Times Cited: 11
Oxidative stress-mediated protein sulfenylation in human diseases: Past, present, and future
Baoquan Mu, Yan Zeng, Li Luo, et al.
Redox Biology (2024) Vol. 76, pp. 103332-103332
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top